FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4317360770> ?p ?o ?g. }

• W4317360770 endingPage "1217" @default.
• W4317360770 startingPage "1208" @default.
• W4317360770 abstract "Intratumoral hypoxia is associated with tumor progression and therapeutic resistance. The VHL tumor suppressor gene was identified in 1993, and later studies revealed that the gene product pVHL interacts with other proteins to form the VBC complex. The VBC complex functions as an E3 ubiquitin ligase and regulates the abundance of the α-subunit of the transcription factor hypoxia-inducible factor (HIF). Hypoxia-inducible factor regulates thousands of genes required for cells to adapt and survive in hypoxic conditions, and thus pVHL plays a major role in oxygen-sensing pathways. Patients with von Hippel-Lindau (VHL) disease, harboring a germline mutation of the VHL gene, develop renal cell carcinomas and a series of tumors showing hypervascular phenotypes. The extensive findings that have clarified the function of VHL have contributed to the development of novel first-in-human drugs, including belzutifan, a HIF-2α inhibitor. The 2019 Nobel Prize in Physiology or Medicine was awarded to Dr. William G. Kaelin Jr., Dr. Peter J. Ratcliffe, and Dr. Gregg L. Semenza as researchers contributing to clarifying the mechanism of the oxygen-sensing pathway of cells. The first report of VHL disease was in 1894, meaning the development of a specific drug for this disease took almost 125 years. In this article, we describe how researchers and clinician scientists successfully clarified the function of VHL and achieved a preclinical proof of concept to apply for clinical trials, key requirements for drug development." @default.
• W4317360770 created "2023-01-19" @default.
• W4317360770 creator A5009447665 @default.
• W4317360770 creator A5025578875 @default.
• W4317360770 creator A5035010277 @default.
• W4317360770 creator A5041281073 @default.
• W4317360770 creator A5043140898 @default.
• W4317360770 date "2023-01-31" @default.
• W4317360770 modified "2023-10-14" @default.
• W4317360770 title "Development of drugs targeting hypoxia‐inducible factor against tumor cells with <i>VHL</i> mutation: Story of 127 years" @default.
• W4317360770 cites W129642105 @default.
• W4317360770 cites W1543034080 @default.
• W4317360770 cites W1721827275 @default.
• W4317360770 cites W1749022239 @default.
• W4317360770 cites W1895938869 @default.
• W4317360770 cites W1970078605 @default.
• W4317360770 cites W1970744454 @default.
• W4317360770 cites W1976752846 @default.
• W4317360770 cites W1978173977 @default.
• W4317360770 cites W1988377666 @default.
• W4317360770 cites W1988935612 @default.
• W4317360770 cites W1989040551 @default.
• W4317360770 cites W1990607537 @default.
• W4317360770 cites W1991421091 @default.
• W4317360770 cites W1992413989 @default.
• W4317360770 cites W1998664010 @default.
• W4317360770 cites W1999966467 @default.
• W4317360770 cites W2005729255 @default.
• W4317360770 cites W2005868568 @default.
• W4317360770 cites W2007914204 @default.
• W4317360770 cites W2010160635 @default.
• W4317360770 cites W2011499154 @default.
• W4317360770 cites W2012911863 @default.
• W4317360770 cites W2015644147 @default.
• W4317360770 cites W2018008610 @default.
• W4317360770 cites W2019521269 @default.
• W4317360770 cites W2021932335 @default.
• W4317360770 cites W2028400858 @default.
• W4317360770 cites W2030869361 @default.
• W4317360770 cites W2031514188 @default.
• W4317360770 cites W2033803279 @default.
• W4317360770 cites W2035855731 @default.
• W4317360770 cites W2040031153 @default.
• W4317360770 cites W2046507292 @default.
• W4317360770 cites W2047361593 @default.
• W4317360770 cites W2047691985 @default.
• W4317360770 cites W2048216460 @default.
• W4317360770 cites W2052201224 @default.
• W4317360770 cites W2057199368 @default.
• W4317360770 cites W2060113755 @default.
• W4317360770 cites W2060525294 @default.
• W4317360770 cites W2062207706 @default.
• W4317360770 cites W2064266243 @default.
• W4317360770 cites W2068555261 @default.
• W4317360770 cites W2072839085 @default.
• W4317360770 cites W2081460564 @default.
• W4317360770 cites W2082331198 @default.
• W4317360770 cites W2087046564 @default.
• W4317360770 cites W2087841059 @default.
• W4317360770 cites W2089692551 @default.
• W4317360770 cites W2090627731 @default.
• W4317360770 cites W2093776019 @default.
• W4317360770 cites W2099697409 @default.
• W4317360770 cites W2100161232 @default.
• W4317360770 cites W2117236885 @default.
• W4317360770 cites W2129346144 @default.
• W4317360770 cites W2130456602 @default.
• W4317360770 cites W2132272301 @default.
• W4317360770 cites W2134960373 @default.
• W4317360770 cites W2144625075 @default.
• W4317360770 cites W2149456801 @default.
• W4317360770 cites W2155584216 @default.
• W4317360770 cites W2159368804 @default.
• W4317360770 cites W2191103386 @default.
• W4317360770 cites W2273992414 @default.
• W4317360770 cites W2343715512 @default.
• W4317360770 cites W2507518506 @default.
• W4317360770 cites W2510079645 @default.
• W4317360770 cites W2513249090 @default.
• W4317360770 cites W2514212469 @default.
• W4317360770 cites W2520967373 @default.
• W4317360770 cites W2551569844 @default.
• W4317360770 cites W2580449060 @default.
• W4317360770 cites W2735034710 @default.
• W4317360770 cites W2778771081 @default.
• W4317360770 cites W2883676103 @default.
• W4317360770 cites W2979284331 @default.
• W4317360770 cites W3022518945 @default.
• W4317360770 cites W3089803871 @default.
• W4317360770 cites W4226406485 @default.
• W4317360770 cites W4317360770 @default.
• W4317360770 doi "https://doi.org/10.1111/cas.15728" @default.
• W4317360770 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36650918" @default.
• W4317360770 hasPublicationYear "2023" @default.
• W4317360770 type Work @default.
• W4317360770 citedByCount "2" @default.
• W4317360770 countsByYear W43173607702023 @default.
• W4317360770 crossrefType "journal-article" @default.

• next